These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7106692)

  • 21. [Chronic hepatitis B. Recent advances in diagnosis and treatment].
    Bernardi M; Biselli M; Gramenzi A
    Recenti Prog Med; 2002; 93(7-8):397-402. PubMed ID: 12138683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P
    Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
    Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approaches to the treatment of chronic hepatitis B viral infection.
    Thomas HC; Lok AS
    Prog Clin Biol Res; 1983; 143():379-93. PubMed ID: 6199798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.
    Dienstag JL; Schiff ER; Mitchell M; Casey DE; Gitlin N; Lissoos T; Gelb LD; Condreay L; Crowther L; Rubin M; Brown N
    Hepatology; 1999 Oct; 30(4):1082-7. PubMed ID: 10498663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects.
    Torrani Cerenzia M; Fiume L; De Bernardi Venon W; Lavezzo B; Brunetto MR; Ponzetto A; Di Stefano G; Busi C; Mattioli A; Gervasi GB; Bonino F; Verme G
    Hepatology; 1996 Apr; 23(4):657-61. PubMed ID: 8666314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic hepatitis type virus B.
    Schalm SW
    Hepatogastroenterology; 1984 Feb; 31(1):12-6. PubMed ID: 6199273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
    Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation.
    Ben-Ari Z; Broida E; Kittai Y; Chagnac A; Tur-Kaspa R
    Am J Gastroenterol; 2000 Dec; 95(12):3579-83. PubMed ID: 11151895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?
    Thakur V; Guptan RC; Malhotra V; Basir SF; Sarin SK
    J Assoc Physicians India; 2002 Nov; 50():1386-94. PubMed ID: 12583467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inapparent "wild-type" and "e-minus variant" HBV infection in patients with HCV-related chronic hepatitis.
    Sardo MA; Rodinò G; Brancatelli S; Pernice M; Campo S; Squadrito G; Russo F; Raimondo G
    Liver; 1994 Oct; 14(5):241-4. PubMed ID: 7997082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
    Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
    Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.